Due to planned site maintenance, you will not be able to access our course learning management system Sunday May 19, 12AM – 4AM ET. Apologies for any inconvenience.
To assess the benefit and harm of transarterial chemoembolization treatment when compared to no intervention or a placebo intervention for patients with liver metastases.
Members Only
Access to this article is restricted. Please log in to view the full article.